NCT05266118

Brief Summary

The overall objective of this study is a) to increase knowledge about ICU patient's symptoms and symptom clusters during the first week after ICU discharge, and b) to identify cognitive, psychological, and physical symptoms and health state at hospital discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 19, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2023

Completed
Last Updated

March 29, 2023

Status Verified

February 1, 2022

Enrollment Period

8 months

First QC Date

January 21, 2022

Last Update Submit

March 28, 2023

Conditions

Keywords

Critical illPICSWardFollow-up careSymptoms and Signs

Outcome Measures

Primary Outcomes (1)

  • Multiple symptoms

    Multiple symptoms is measured with the Memorial Symptoms Assessment Scale (MSAS).The patients will be asked to indicate whether they experience 32 different symptoms (i.e., occurence). Those who experience a symptom will be asked to rate its frequency (from rarely \[1 point\] to almost constantly \[4 points\]); intensity (from slight \[1 p\] to very severe \[4 p\]); and distress or bother (from not at all \[0 p\] to very much \[4 p\]). Here, higher score indicate worse symptom experience.

    Up to 1 week after ICU discharge

Secondary Outcomes (6)

  • Cognitive symptoms

    At hospital discharge, an average of one week

  • Posttraumatic stress symptoms

    At hospital discharge, an average of one week

  • Anxiety and depression

    At hospital discharge, an average of one week

  • Physical symptoms

    At hospital discharge, an average of one week

  • Health status

    At hospital discharge, an average of one week

  • +1 more secondary outcomes

Study Arms (1)

Former ICU patients

Participants is former ICU patients, immediately after transferred from ICU to a hospital ward. At least one of these criteria is needed for the participation in the study: ICU stays \> 24 hours; ventilatory support; transferals to other ICU \< 24 hours; continuous infusion of vasoactive substances. In addition, to be included, the patients must be more than 18 years of age; understand and be able to write and read Norwegian; be able to communicate verbally; not have a manifest cognitive deficit; and not being readmitted to ICU \< 72 hours

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target group of this study is former ICU patients. The patients will be recruited from a hospital in the South-Eastern part of Norway. In this hospital, ICU patients are treated in two different ICUs, one eight-bed mixed medical/surgical ICU (treating patients with both non-invasive and invasive mechanical ventilation) and one ten-bed medical ICU (treating patients with non-invasive ventilation only). The hospital wards may be both surgical and medical wards.

You may qualify if:

  • At least one of these criteria is needed for the participation in the study:
  • ICU stays \> 24 hours
  • Ventilatory support
  • Transferals to other ICU \< 24 hours
  • Continuous infusion of vasoactive substances

You may not qualify if:

  • Not able to understand, read or write Norwegian
  • Not able to communicate verbally
  • A manifest cognitive deficit (e.g., dementia or delirium)
  • Re-admission to ICU \< 72 timer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ostfold Hospital Trust

Sarpsborg, Gralum, 1714, Norway

Location

Østfold Hospital Trust

Sarpsborg, Gralum, 1714, Norway

Location

MeSH Terms

Conditions

Signs and SymptomsSyndromeCritical Illness

Condition Hierarchy (Ancestors)

Pathological Conditions, Signs and SymptomsDiseasePathologic ProcessesDisease Attributes

Study Officials

  • Brita Fosser Olsen, RN,PhD

    Østfold Hospital Trust Postbox 300, 1714 Grålum, Norway

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2022

First Posted

March 4, 2022

Study Start

April 19, 2022

Primary Completion

December 21, 2022

Study Completion

March 2, 2023

Last Updated

March 29, 2023

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations